Dermatologic Reactions to Immune Checkpoint Inhibitors

This review describes the variable clinical and histopathologic aspects of dermatologic irAEs induced by immune checkpoint inhibitors, with a step-by-step approach for optimized management by both practicing oncologists and dermatologists.